AXGN Q1 2021 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q1 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$31M+27.9% YoY

Gross Profit

$26M83.3% margin

Operating Income

-$6M-20.0% margin

Net Income

-$7M-21.5% margin

EPS (Diluted)

$-0.16

QoQ Revenue Growth

-4.5%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$14M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$197M

Total Liabilities

$78M

Stockholders' Equity

$120M

Cash & Equivalents

$40M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$31M	$24M	+27.9%
Gross Profit	$26M	$19M	+33.0%
Operating Income	-$6M	-$9M	+26.9%
Net Income	-$7M	-$8M	+18.7%